克利夫兰生物实验室(CBLI.US)盘前大涨18.76%,报5.76美元。公司与美国细胞通信公司Cytocom宣布合并登记声明和委托声明。 网页链接
$克利夫兰生物实验室(CBLI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-12 AccNo: 0001318641-18-000011 Size: 714 KB 网页链接
$克利夫兰生物实验室(CBLI)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-12 AccNo: 0001318641-18-000010 Size: 734 KB 网页链接
$克利夫兰生物实验室(CBLI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-12 AccNo: 0001318641-18-000011 Size: 714 KB 网页链接
$克利夫兰生物实验室(CBLI)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-12 AccNo: 0001318641-18-000010 Size: 734 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2018-03-06 AccNo: 0001318641-18-000007 Size: 173 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$克利夫兰生物实验室(CBLI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-06 AccNo: 0001318641-18-000005 Size: 5 MB 网页链接
$克利夫兰生物实验室(CBLI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-28 AccNo: 0001213900-18-002383 Size: 44 KB 网页链接
$克利夫兰生物实验室(CBLI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-04 AccNo: 0001535610-18-000008 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ CT ORDER - Confidential treatment order Filed: 2017-11-17 AccNo: 9999999997-17-009945 Size: 10 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2017-11-14 AccNo: 0001318641-17-000045 Size: 169 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接